Similar articles

• Low-dose intradermal versus intramuscular trivalent inactivated seasonal influenza vaccine in lung transplant recipients.

  Manuel O, Humar A, Berutto C, Ely L, Giulieri S, Lien D, Meylan PR, Weinkauf J, Pascual M, Nador R, Aubert JD, Kumar D. Manuel O, et al. J Heart Lung Transplant. 2011 Jun;30(6):679-84. doi: 10.1016/j.healun.2011.01.705. Epub 2011 Mar 5. J Heart Lung Transplant. 2011. PMID: 21377898 Clinical Trial.
• Debate on annual influenza vaccination in healthcare workers for the same subtype under the vaccine shortage.

  Song JY, Ha SH, Kee SY, Jeong HW, Cheong HJ, Kim WJ. Song JY, et al. J Clin Virol. 2007 Feb;38(2):149-52. doi: 10.1016/j.jcv.2006.08.022. Epub 2006 Dec 29. J Clin Virol. 2007. PMID: 17196876 Clinical Trial.
• Dose-related safety and immunogenicity of baculovirus-expressed trivalent influenza vaccine: a double-blind, controlled trial in adult patients with non-Hodgkin B cell lymphoma.

  Safdar A, Rodriguez MA, Fayad LE, Rodriguez GH, Pro B, Wang M, Romaguera JE, Goy AH, Hagemeister FB, McLaughlin P, Bodey GP, Kwak LW, Raad II, Couch RB. Safdar A, et al. J Infect Dis. 2006 Nov 15;194(10):1394-7. doi: 10.1086/508493. Epub 2006 Oct 6. J Infect Dis. 2006. PMID: 17054068 Clinical Trial.
• Rapid decline of influenza vaccine-induced antibody in the elderly: is it real, or is it relevant?

  Skowronski DM, Tweed SA, De Serres G. Skowronski DM, et al. J Infect Dis. 2008 Feb 15;197(4):490-502. doi: 10.1086/524146. J Infect Dis. 2008. PMID: 18275271 Review.
• Seasonal trivalent influenza vaccine for 2010-2011.

  [No authors listed] [No authors listed] Med Lett Drugs Ther. 2010 Oct 4;52(1348):77-9. Med Lett Drugs Ther. 2010. PMID: 20885341 Review. No abstract available.